NAXEPRY

Serial Number 98757382
730

Registration Progress

Application Filed
Sep 18, 2024
Under Examination
Jun 17, 2025
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 17, 2026 148 days

Trademark Image

NAXEPRY

Basic Information

Serial Number
98757382
Filing Date
September 18, 2024
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jul 11, 2025
Application
Pending
Classes
005 016 044

Rights Holder

AMPHASTAR PHARMACEUTICALS, INC.

03
Address
11570 Sixth Street
Rancho Cucamonga, CA 91730

Ownership History

AMPHASTAR PHARMACEUTICALS, INC.

Original Applicant
03
Rancho Cucamonga, CA

AMPHASTAR PHARMACEUTICALS, INC.

Owner at Publication
03
Rancho Cucamonga, CA

Legal Representation

Attorney
Bethany J. Whelan

USPTO Deadlines

Next Deadline
148 days remaining
NOA E-Mailed - SOU Required
Due Date
June 17, 2026
Extension Available
Until December 17, 2026

Application History

12 events
Date Code Type Description Documents
Jul 12, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 11, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 26, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 25, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 18, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Nasal spray preparations; nasal sprays for medical purposes; nasal spray preparations for use in treating Type 1 anaphylaxis reactions; pharmaceutical formulations for use in treating Type 1 anaphylaxis reactions
Class 016
Printed matter, namely, brochures, leaflets, and manuals in the field of pharmaceuticals, pharmaceutical research, and healthcare
Class 044
Providing a website featuring medical information; providing information relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals

Classification

International Classes
005 016 044